Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=zept20 European Journal of Psychotraumatology ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/zept20 Attenuated psychotic symptoms, substance use and self-reported PTSD in adolescence Lukas Andreas Basedow, Melina Felicitas Wiedmann, Sören Kuitunen-Paul, Veit Roessner & Yulia Golub To cite this article: Lukas Andreas Basedow, Melina Felicitas Wiedmann, Sören Kuitunen-Paul, Veit Roessner & Yulia Golub (2023) Attenuated psychotic symptoms, substance use and self- reported PTSD in adolescence, European Journal of Psychotraumatology, 14:2, 2193327, DOI: 10.1080/20008066.2023.2193327 To link to this article: https://doi.org/10.1080/20008066.2023.2193327 © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group Published online: 03 Apr 2023. Submit your article to this journal Article views: 912 View related articles View Crossmark data https://www.tandfonline.com/action/journalInformation?journalCode=zept20 https://www.tandfonline.com/loi/zept20 https://www.tandfonline.com/action/showCitFormats?doi=10.1080/20008066.2023.2193327 https://doi.org/10.1080/20008066.2023.2193327 https://www.tandfonline.com/action/authorSubmission?journalCode=zept20&show=instructions https://www.tandfonline.com/action/authorSubmission?journalCode=zept20&show=instructions https://www.tandfonline.com/doi/mlt/10.1080/20008066.2023.2193327 https://www.tandfonline.com/doi/mlt/10.1080/20008066.2023.2193327 http://crossmark.crossref.org/dialog/?doi=10.1080/20008066.2023.2193327&domain=pdf&date_stamp=03 Apr 2023 http://crossmark.crossref.org/dialog/?doi=10.1080/20008066.2023.2193327&domain=pdf&date_stamp=03 Apr 2023 CLINICAL RESEARCH ARTICLE Attenuated psychotic symptoms, substance use and self-reported PTSD in adolescence Lukas Andreas Basedow a,b, Melina Felicitas Wiedmann b, Sören Kuitunen-Paul b,c, Veit Roessner b and Yulia Golub b aDepartment of Psychology, Division of Clinical Psychology and Psychotherapy, Philipps-University of Marburg, Marburg, Germany; bDepartment of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany; cClinical Psychology and Psychotherapy, TU Chemnitz, Chemnitz, Germany ABSTRACT Background: The occurrence of attenuated psychotic symptoms (APS) is a major concern in populations with substance use disorders (SUDs). However, APS also frequently develop in the course of Post-Traumatic Stress Disorder (PTSD). This study explores how the prevalence of APS differs between adolescent patients with only SUD, SUD with a history of traumatic experiences (TEs), and with SUD and self-reported PTSD. Methods: We recruited n = 120 treatment-seeking adolescents at a German outpatient clinic for adolescentswith SUD. All participants filled out questionnaires assessing APS (PQ-16, YSR schizoid scale), trauma history, PTSD symptoms (both UCLA PTSD Index), and SUD severity (DUDIT) next to anextensive substanceuse interview.Weperformedamultivariate analysis of co-variancewith the four PQ-16 scales and the YSR scale as outcomes and PTSD status as predictor. Additionally, we performed five linear regressions predicting each PQ-16 score and YSR score based on tobacco, alcohol, cannabis, ecstasy, amphetamine, and methamphetamine use. Results: Participants with co-occurring SUD and self-reported PTSD showed significantly higher APS prevalence rates (PQ-16 score, p = .00002), more disturbed thought content (p = .000004), more perceptual disturbances (p = .002), more negative symptoms (p = .004) and more thought problems (p = .001) compared to adolescents with SUD and a history of trauma and adolescents with only SUD. Past-year substance use was not predictive for APS prevalence (F (75) = 0.42; p = .86; R2 = .04). Conclusion: Our data suggests that the occurrence of APS in adolescents with SUD is better explained by co-occurring self-reported PTSD than by substance use frequency or substance class. This finding might indicate that APS might be reduced through treating PTSD or focusing on TEs in SUD therapy. Síntomas psicóticos atenuados, consumo de sustancias y TEPT autodeclarado en la adolescencia Antecedentes: La aparición de síntomas psicóticos atenuados (APS por sus siglas en inglés) es una preocupación importante en poblaciones con trastornos por uso de sustancias (SUD por sus siglas en ingles). Sin embargo, los APS también se desarrollan con frecuencia en el curso del Trastorno de Estrés Postraumático (TEPT). Este estudio explora cómo la prevalencia de APS difiere entre pacientes adolescentes con sólo SUD, SUD con una historia de experiencias traumáticas (TEs), y con SUD y TEPT autoinformado. Métodos: Reclutamos n = 120 adolescentes que buscaban tratamiento en una clínica ambulatoria alemana para adolescentes con SUD. Todos los participantes rellenaron cuestionarios que evaluaban APS (PQ-16, escala esquizoide YSR), historia de traumas, síntomas de TEPT (ambos el Índice de TEPT de la UCLA) y la gravedad de la SUD (DUDIT) junto a una extensa entrevista sobre consumo de sustancias. Realizamos un análisis multivariante de covarianza con las cuatro escalas PQ-16 y la escala YSR como resultados y el estado de TEPT como predictor. Además, realizamos cinco regresiones lineales prediciendo cada puntuación PQ-16 y la puntuación YSR en función del consumo de tabaco, alcohol, cannabis, éxtasis, anfetaminas y metanfetaminas. Resultados: Los participantes con SUD concurrente y TEPT autoinformado mostraron tasas de prevalencia de APS significativamente más altas (puntuación PQ-16, p = .00002), un contenido de pensamiento más perturbado (p = .000004), más alteraciones perceptivas (p = .002), más síntomas negativos (p = .004) y más problemas del pensamiento (p = .001) en comparación con los adolescentes con SUD y antecedentes de trauma y los adolescentes con sólo SUD. El consumo de sustancias durante el año anterior no fue predictivo de la prevalencia de APS (F (75) = 0,42; p = 0,86; R2 = 0,04). ARTICLE HISTORY Received 25 January 2023 Revised 8 March 2023 Accepted 8 March 2023 KEYWORDS Addiction; trauma; psychosis; drug use; adolescent PALABRAS CLAVE Adicción; trauma; psicosis; consumo de drogas; adolescente 关键词 成瘾;创伤;精神病;药物使 用; 青少年 HIGHLIGHTS • Adolescents with co- occurring substance use disorders and PTSD show increased rates of Attenuated Psychotic Symptoms (APS). • A history of traumatic experiences and PTSD are stronger predictors for APS than substance use. • APS in adolescents with substance use disorders may be an indication of undiagnosed and/or untreated co-occurring PTSD. © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. CONTACT Lukas Andreas Basedow lukas.basedow@uni-marburg.de Department of Psychology, Division of Clinical Psychology and Psy- chotherapy, Philipps-University of Marburg, Gutenbergstr. 18, Marburg 35037, Germany EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 2023, VOL. 14, NO. 2, 2193327 https://doi.org/10.1080/20008066.2023.2193327 http://crossmark.crossref.org/dialog/?doi=10.1080/20008066.2023.2193327&domain=pdf&date_stamp=2023-03-30 http://orcid.org/0000-0003-4866-8686 http://orcid.org/0000-0001-7250-4329 http://orcid.org/0000-0001-8224-6490 http://orcid.org/0000-0002-1873-7081 http://orcid.org/0000-0002-9191-5884 http://creativecommons.org/licenses/by-nc/4.0/ mailto:lukas.basedow@uni-marburg.de http://www.tandfonline.com Conclusiones: Nuestros datos sugieren que la aparición de APS en adolescentes con SUD se explica mejor por el TEPT autoinformado co-ocurrente que por la frecuencia de uso de sustancias o la clase de sustancia. Este hallazgo podría indicar que los APS podría reducirse mediante el tratamiento del TEPT o centrándose en los TE en la terapia del SUD. 青少年中轻微的精神病症状、物质使用和自我报告的 PTSD 背景：轻微精神病症状 (APS) 的发生是物质使用障碍 (SUD) 人群的主要关注点。 然而，APS 也经常在创伤后应激障碍 (PTSD) 的过程中发展。 本研究探讨了 APS 的患病率在仅患有 SUD、有创伤经历 (TE) 史的 SUD 以及患有 SUD 和自我报告的 PTSD 的青少年患者之间有 何不同。 方法：我们在德国 SUD 青少年门诊招募了120 名寻求治疗的青少年。 所有参与者都在广泛 性物质使用访谈后填写了评估 APS（PQ-16，YSR 分裂样量表）、创伤史和PTSD 症状（均 使用UCLA PTSD 指数）和 SUD 严重程度 (DUDIT) 的问卷。 我们用四个 PQ-16 量表和 YSR 量表作为结果，PTSD 状态作为预测因子，进行了协方差的多变量分析。 此外，我们根据 烟草、酒精、大麻、摇头丸、苯丙胺和甲基苯丙胺的使用情况，进行了五项线性回归预测 每个 PQ-16 评分和 YSR 评分。 结果：同时患有 SUD 和自我报告的 PTSD 的参与者相较于患有 SUD 且有创伤史的青少年和 仅患有 SUD的青少年，表现出显著更高的 APS患病率（PQ-16评分，p = .00002）、更不安 的思想内容（p = .000004）、更多的知觉障碍（p = .002） )，更多的阴性症状 (p = .004) 和 更多的思维问题 (p = .001)。 过去一年的物质使用不能预测 APS 患病率 (F(75) = 0.42；p = .86；R2 = .04)。 结论：我们的数据表明，与物质使用频率或物质类别相比，同时发生的自我报告的 PTSD 可以更好地解释患有 SUD 的青少年 APS 的发生。 这一发现可能表明通过治疗 PTSD 或在 SUD 治疗中关注 TE 可能会降低 APS。 Trial registration: ClinicalTrials.gov identifier: NCT03444974. 1. Background Early identification of individuals with an increased risk for psychotic disorders is one of the most impor- tant prerequisites for their efficient prevention and treatment. Attenuated psychotic syndrome (American Psychiatric Association & American Psychiatric Association, 2013) also known as attenuated psychotic symptoms (APS) are strong indicators of a patient being at ultra-high risk of developing psychosis (Fusar-Poli et al., 2013, 2016). APS refers to the pres- ence of subthreshold symptoms of a psychotic episode, such as unusual thought content, suspiciousness, grandiose ideas, perceptual abnormalities, or disorga- nised communication (Salazar de Pablo et al., 2020). APS are considered to be present if one of the symp- toms listed above reaches clinically significant disturb- ance below psychotic intensity (McGlashan et al., 2010). Even though self-reported APS are less predic- tive than clinician-reported symptoms (Fusar-Poli et al., 2017), self-reported APS are still associated with a four-fold risk of subsequent hospitalisation for a psy- chotic disorder and a two-fold risk of hospitalisation for other mental disorders (Werbeloff et al., 2012). Accordingly, the concept of APS is a useful tool to identify individuals that have an increased risk of devel- oping a psychotic disorder (Arango, 2011).However, as mentioned above APS are not only indicative of future psychotic disorders but are also associated with other mental disorders, making it necessary to carefully assess the diagnostic specificity of reported APS (Gau- diano & Zimmerman, 2012; Rosen et al., 2006). Substance use and substance use disorders (SUDs) are strongly linked to psychosis and APS (Matheson et al., 2022). For instance, 50% of patients with a first episode of psychosis present with a co-occurring SUD (Brunette et al., 2018). Furthermore, the severity of SUD is positively correlated with increased APS prevalence (Smith et al., 2009). This relationship seen in adult patients can also be observed in adolescents. Substance use, particularly cannabis and ecstasy use by adolescents, is associated with a high-risk for psychosis (Carney et al., 2017; Wiedmann, Kuitunen-Paul, et al., 2022) and admis- sion due to psychotic symptoms (Baeza et al., 2009; Schimmelmann et al., 2012). At present a co-occurrence of APS and SUD is commonly interpreted as an indicator of a high risk for a prodromal stage of substance-induced psychosis (Beckmann et al., 2020). However, APS are diagnostically diverse and ado- lescents with SUD also present with other mental dis- order (Kuitunen-Paul et al., 2021; Wiedmann, Atzendorf, et al., 2022), thus it is possible that co- occurrence of SUD and APS might be related to yet another factor. One of these factors may be the high incidence of traumatic experiences (TEs) or post-traumatic stress disorder (PTSD) in adolescents with SUD (Basedow et al., 2020). Previous research has shown that TEs are highly prevalent in adolescent who report APS (Fusar-Poli, Tantardini, et al., 2017; Kelleher et al., 2008) and that TEs stay a significant predictor for 2 L. A. BASEDOW ET AL. APS even when taking substance use into account (Wiedmann, Kuitunen-Paul, et al., 2022). Specific APS that are associated with TEs and PTSD are suspi- ciousness and grandiose ideas (Falukozi & Addington, 2012) as well as perceptual abnormalities (Scott et al., 2007; Simon et al., 2014). One reason why APS are related to trauma related disorders could be a trauma-induced stress sensitivity which increases the risk for later APS development through alterations of the neurobiological stress system (Holtzman et al., 2013). In previous studies PTSD and TEs have often been grouped together as a single risk factor for APS, however, it remains to be investigated whether individuals with TEs but not PTSD suffer from APS at a similar rate as patients with PTSD. Thus it is not clear how the presence of TEs and/or PTSD in adolescent patients with SUD relates to prevalence of APS. This knowledge is important especially for clin- icians to make correct diagnostic decisions and choose appropriate treatment strategies. We aimed to explore if a history of TEs or a current PTSD can predict APS in adolescents with SUDs. In addition we investigated associations between past- year use estimates for different psychoactive sub- stances and current APS. 2. Methods 2.1. Participants Between November 2017 and December 2022, n = 120 treatment-seeking adolescents at a German outpatient clinic for adolescents with SUD consented to partici- pate in the study and filled out all relevant question- naires. Participants were divided into three groups according to their trauma status resulting from a PTSD questionnaire: patients with SUDwithout history of traumatic experiences (‘No TEs’), patients with SUD with a history of TEs but no current PTSD (‘TEs’), and patients with SUD and self-reported PTSD (‘PTSD’). Notably, adolescent patients did not qualify for acute (drug-induced) psychosis or psychotic symptoms that would have required treatment. 2.2. Procedure Data collection was embedded into the standard diag- nostic procedures at the Outpatient Clinic for Adoles- cent Substance Abuse, University Hospital C. G. Carus Dresden, Germany, see study protocol NCT03444974 registered at clinicaltrials.gov. Questionnaires were handed out to patients and their legal guardians at the first consultation appointment. The sample was collected via consecutive admission of treatment-seek- ing patients. The criteria for SUDs according to ICD- 10 were assessed in an admission interview by a trained clinical psychologist. The admission interview only includes a proper interview section for SUD cri- teria, while criteria for other mental disorders are screened for via questionnaires. The study was con- ducted in accordance with the Declaration of Helsinki and all procedures were approved by the Institutional Review Board of the University Hospital C. G. Carus Dresden (EK 66022018). 2.3. Measures Attenuated psychotic symptoms. The German 16- Item short version (PQ-16) (Ising et al., 2012) of the Prodromal Questionnaire (PQ) (Loewy et al., 2005) is a screening questionnaire assessing the presence of APS in the past month on a two-point scale (true/ false) and subjective load on a four-point Likert scale ranging from 0 (‘not at all’) to 3 (‘very much’). The PQ-16 questionnaire provides a total score for all 16 items and three additional subscales: unusual thought content/delusional ideas (5 items), perceptual abnormalities/hallucinations (9 items) and negative symptoms (2 items). The questionnaire is validated for use in adolescents with a cut-total score of 7 indi- cating high-risk status for psychosis (de Jong et al., 2020) Thought problems. The Youth Self-Report (YSR/ 11-18) (Arbeitsgruppe Deutsche Child Behavior Checklist, 1998) is a questionnaire on which adoles- cents rate their behavioural, emotional, social and physical problems for the previous six months. The questionnaire consists of 120 items with three response options (0 = ‘not applicable’, 1 = ‘sometimes’, 2 = ‘frequently’). For this project, we only analysed the total score on the thought problem subscale (6 items) as a dependent variable (DV). Substance use disorder severity. The Drug Use Disorders Identification Test (DUDIT) (Voluse et al., 2012) is a self-report instrument composed of 11 items related to problems with illegal substance use, deemed reliable for the use in adolescents (Basedow, Kuitunen-Paul, Eichler, et al., 2021). Scoring of the DUDIT is two-fold: items one to nine are scored on a five-point Likert scale, while items ten and eleven are scored on a three-point scale. DV was the total DUDIT score. Trauma status and PTSD symptoms. The Ger- man version (Ruf et al., 2011) of the Post Traumatic Stress Disorder Reaction Index for DSM-IV (Stein- berg et al., 2004) is a questionnaire assessing lifetime TEs and current PTSD symptoms in adolescents. In the questionnaire, participants select the frequency of occurrence of PTSD symptoms during the past month (rated from 0 = ‘none of the time’ to 4 = ‘most of the time’). The items map directly onto the DSM-IV intrusion (Criterion B), avoidance (Cri- terion C), and hyperarousal (Criterion D) symptoms. Criterion A is fulfilled if one of the listed traumatic EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 3 http://clinicaltrials.gov situations is checked off as having happened to the participant. Criterion B is fulfilled if one of five intrusion items is rated as 2 (=some of the time) or higher. Criterion C is fulfilled if three out of nine avoidance items are rated as 2 or higher. Cri- terion D is fulfilled if two out of six hyperarousal items are rates 2 or higher. These criteria are based on psychometric validation studies (Elhai et al., 2013; Steinberg et al., 2013) and have been applied in clinical settings (Oswald et al., 2010). Since this questionnaire is a self-report measure and does not include clinical judgment, we considered PTSD as probable and not as established when all four criteria (criterion A, B, C, & D) are fulfilled (Steinberg et al., 2004). DVs for this questionnaire were the probable presence of a PTSD (yes/no) and whether TEs were reported (yes/no). Substance use. The pattern of substance use was assessed via an interview (Golub et al., 2021), asking for the number of days each substance was used per month over the past year and for the average quantity of used substance per day. DV from this assessment was calculated by multiplying the average number of use days with the average daily amount per substance used, resulting in the estimated average amount of substance used per month (e.g. grams of cannabis per month). Assessed substances were tobacco (ciga- rettes), alcohol, cannabis, ecstasy, amphetamine, and methamphetamine. 2.4. Statistical analysis All calculations were performed with IBM SPSS 27 (IBM, 2020). Descriptive group differences in age, gender, and substance use variables were assessed with ANOVA, chi-square test and MANOVA respectively. The three groups differed only in terms of their gender distribution (see Table 1). Therefore, we performed a two-way MANOVA with group (‘no TEs’, ‘TEs’, ‘PTSD’) and gender (male, female) as factors and the four PQ-16 scales as outcomes. Since not all participants filled out the YSR thought problems scale, we performed a separate two-way ANOVA with only the YSR scale as out- come. When the group effect was significant, post- hoc t-tests were performed to compare the differ- ences on the significant scale between each group, corrected for false-positives via the Bonferroni method (Bland & Altman, 1995). To investigate the association between substance use variables and each of the four PQ-16 scales as well as the YSR thought problems scale, we performed five linear regressions with substance use variables (DUDIT score, cigarette, alcohol, cannabis, ecstasy, amphet- amine, methamphetamine use) as predictors. Significance level was set to p < .05. Effect sizes were classified according to Cohen (1988) into small effects (|η2|≥ .01; |b|≥ .10), medium effects (|η2|≥ .06; | b|≥ .30), and large effects (|η2|≥ .14; |b|≥ .50). 3. Results 3.1. Participants The three groups of participants did not differ in terms of age (F (119) = 0.44, p = .649), but in terms of their gender distribution (X2(2) = 11.39, p = .003), with the No TEs group having a lower percentage of female participants, see Table 1 for details. 3.2. APS in adolescents with SUD We observed a group (‘no TEs’ vs. ‘TEs’ vs. ‘PTSD’) effect on PQ-16 scores among adolescent patients with SUD (F(226) = 4.74, p = .0001, η2 = .112), but no interaction effect between group and gender (F (226) = 1.24, p = .286, η2 = .032). The three groups (‘no TEs’, ‘TEs’, ‘PTSD’) differed in terms of their total PQ-16 score (F(114) = 11.99, p = .00002, η2 = .174), disturbed thought content (F(114) = 13.92, p = .000004, η2 = .196), perceptual disturbances (F (114) = 6.60, p = .002, η2 = .104), and negative symp- toms (F(114) = 5.92, p = .004, η2 = .094). Furthermore, the MANOVA also showed a group effect on the YSR thought problem scale (F(53) = 7.67, p = .001, η2 = .242) and again no interaction effect of group and gender (F(53) = 0.27, p = .768, η2 Table 1. Demographic details of participants. SUD and No TEs (n = 33) SUD and TEs (n = 47) SUD and PTSD (n = 40) Group comparison Test statistic (df) p- value Effect size (η2) Age in years; M (SD) 15.8 (1.4) 15.9 (1.3) 16.1 (1.2) F (119) = 0.44 .649 η2 = .007 % of female patients 24.2% 38.3% 62.5% X2 (2) = 11.39 .003* V = .22 DUDIT score; M (SD) 16.2 (10.2) 16.5 (9.8) 19.3 (11.3) F (117) = 1.06 .350 η2 = .018 Substance units per month over past year; M (SD) Number of cigarettes 275.5 (278.8) 339.1 (284.0) 311.1 (267.2) F (75) = 0.58 .562 η2 = .016 Alcoholic standard drinks 58.6 (116.1) 107.1 (242.1) 125.0 (205.1) F (75) = 0.91 .405 η2 = .024 Grams of cannabis 47.3 (86.1) 59.0 (81.0) 37.4 (49.5) F (75) = 0.87 .425 η2 = .023 Number of ecstasy pills 3.64 (9.6) 0.8 (1.8) 12.4 (33.1) F (75) = 2.32 .106 η2 = .060 Grams of amphetamine 0.9 (3.7) 1.1 (4.9) 0.4 (1.1) F (75) = 0.52 .595 η2 = .014 Grams of methamphetamine 0.6 (2.7) 5.8 (24.7) 9.0 (33.0) F (75) = 0.83 .440 η2 = .022 Note: DUDIT, Drug Use Disorder Identification Test; TE, Traumatic Event; PTSD, Post-traumatic stress disorder. 4 L. A. BASEDOW ET AL. = .011). Based on their effect sizes, all effects are at least of medium size, and the group differences in total PQ- 16 score, disturbed thought content and YSR thought problems were large. Post-hoc analysis revealed that the ‘PTSD’ group scored higher on each PQ-16 sub- scale as well as the YSR thought problem scale, com- pared to the ‘No TEs’ and ‘TEs’ group, see Table 2. All comparisons between the ‘no TEs’ and ‘TEs’ group were not statistically significant. 3.3. Association of substance use with APS Substance use variables (tobacco, alcohol, cannabis, ecstasy, amphetamine, methamphetamine use) were not significantly associated with PQ-16 total score (F (75) = 0.42; p = .86; R2 = .04), PQ-16 thought disturb- ance (F(75) = 0.64; p = .70; R2 = .05), PQ-16 perceptual symptoms (F(75) = 0.43; p = .86; R2 = .04), PQ-16 negative symptoms (F(75) = 0.22; p = .75; R2 = .05), or YSR thought problems (F(35) = 2.31; p = .06; R2 = .32). See Table 3, for an overview over standardised coefficients and test results for each variable in each regression model. 4. Discussion In the present study, we investigated whether the extent of APS is associated with a lifetime history of TEs or an additional self-reported PTSD in adolescent SUD outpatients without acute psychotic symptoms. We showed that patients with the combination of SUD and self-reported PTSD show higher levels of APS in each assessed domain than patients with SUD without self-reported PTSD even if they have a lifetime history of TEs. The frequency of substance use and severity of SUD were not related to levels of APS. On one hand these results confirm previous findings relating the presence of PTSD to an increased level of APS (Simon et al., 2014) and indicate that an increased level of APS in adolescent patients with SUD might be due to this association. Patients with a history of TEs but not PTSD might also be exposed to protective factors, such as social support (McCrory et al., 2022), that protect from development of PTSD as well as APS. Furthermore, our findings are not in line with findings associating substance use, and ecstasy use specifically, with APS. For example, case reports indi- cate that ecstasy users might develop psychotic-like symptoms or depersonalisation (Majić et al., 2022; Vaiva et al., 2001; Virani et al., 2018) and empirical studies have shown an association between ecstasy use and APS (Duman et al., 2017; Wiedmann, Kuitu- nen-Paul, et al., 2022), as well as ecstasy use and PTSD (Basedow et al., 2022; Basedow, Kuitunen-Paul, Wied- mann, et al., 2021). One reason for this discrepancy might be the specific form of assessment and inclusion criteria applied in our study. First, our main outcome variable (PQ-16 score) only assesses APS occurrence in the past month. Second, patients with acute psycho- tic state were not admitted to our clinic, excluding them from participation in this study. Therefore, it is possible that substance-induced APS are indeed rare and instead substance use is more strongly related to fully developed psychotic symptoms. Table 2. Means and multiple comparisons. SUD and No TEs (n = 33) SUD and TEs (n = 47) SUD and PTSD (n = 40) Means and standard deviations PQ-16 – total 3.27 (3.1) 3.77 (3.3) 7.00 (4.0) PQ-16 – thought 1.30 (1.2) 1.60 (1.3) 2.90 (1.4) PQ-16 – perceptual 1.30 (1.9) 1.64 (2.0) 3.08 (2.6) PQ-16 – negative 0.67 (0.5) 0.53 (0.7) 1.08 (0.7) YSR – thought problems 55.46 (6.6) 55.55 (8.3) 65.62 (8.3) Multiple Comparisons* No TEs vs. PTSD TEs vs. PTSD PQ-16 – total Diff. = |3.73|, t (71) =−4.41, p = .00005 Diff. = |3.23|, t (85) =−4.15, p = .0001 PQ-16 – thought Diff. = |1.55|, t (71) =−4.89, p = .000007 Diff. = |1.25|, t (85) =−4.33, p = .00007 PQ-16 – perceptual Diff. = |1.77|, t (71) =−3.24, p = .003 Diff. = |1.44|, t (85) =−2.90, p = .010 PQ-16 – negative Diff. = |0.41|, t (71) =−2.67, p = .029 Diff. = |0.54|, t (85) =−3.57, p = .0006 YSR – thought problems Diff. = |10.16|, t (32) =−3.73, p = .003 Diff. = |10.07|, t (39) =−3.88, p = .0007 Note: *only statistically significant post-hoc tests are displayed. All comparisons between the ‘no TEs’ and ‘TE’ group were non-significant. PQ-16, Prodro- mal Questionnaire 16-item version; YSR, Youth Safe Report; TE, Traumatic Event; PTSD, Post-traumatic stress disorder; Diff., mean difference between groups. Table 3. Regression coefficients for the five performed regression analyses. PQ-16 – total PQ-16 – thought PQ-16 – perceptual PQ-16 – negative YSR – thought problems Tobacco b =−.075; p = .628 b =−.067; p = .666 b =−.031; p = .840 b =−.091; p = .555 b =−.347; p = .109 Alcohol b = .104; p = .474 b = .034; p = .813 b =−.067; p = .648 b = .164; p = .262 b = .342; p = .094 Cannabis b = .154; p = .205 b = .138; p = .260 b = .105; p = .392 b = .059; p = .626 b = .177; p = .280 Ecstasy b =−007; p = .952 b =−.025; p = .842 b =−.058; p = .643 b = .034; p = .783 b = .451; p = .007 Amphetamine b =−.128; p = .287 b =−.111; p = .360 b =−.085; p = .483 b =−.036; p = .766 b =−.263; p = .140 Methamphetamine b = .123; p = .319 b = .100; p = .423 b = .118; p = .346 b =−.118; p = .342 b = .034; p = .851 Note: PQ-16, Prodromal Questionnaire 16-item version; YSR, Youth Safe Report. EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 5 However, when investigating the substance-specific relationship between use frequency and APS, we found no association between ecstasy use (or other substances for that matter) and APS scores in our data. This is a further indication, that APS might be specifically related to the presence of PTSD, while fully developed psychotic syndromes might be more reliably induced by substance use. This conclusion is also in line with previous research that has shown that TEs in childhood and subsequent PTSD increase the risk of experiencing APS (Frydecka et al., 2020; Hodgekins et al., 2018; Varese et al., 2012) and are a stronger predictor of APS than substance use (Mongan et al., 2019). The association of PTSD with APS in patients with SUD might be mediated by symptoms of borderline person- ality disorder, disturbances of self (e.g. depersonalisa- tion or derealization) and cognitive biases, all of which have been associated with APS (Gawęda et al., 2019; Pionke-Ubych et al., 2021; Sengutta et al., 2019). Specifically, disturbed social processes and attachment issues as seen in borderline personality disorders are also prevalent in SUDs (Gąsior, 2018; Hanegraaf et al., 2021) while cognitive biases play a major role in the development of SUDs (McCusker, 2001) and are an important target for novel SUD interventions (Cristea et al., 2016; Wiers et al., 2013). These connec- tions support the notion that PTSD induces alterations in social and cognitive processes that in turn increase the likelihood of subsequent APS and SUD develop- ment, therefore indicating that APS in adolescent patients with SUD might reflect a presence of PTSD rather than a prodromal substance-induced psychosis. This line of reasoning is supported by other research indicating that APS are not necessarily an indication of clinically verified psychotic experience but can be seen as more general markers of psychopathology (Moriyama et al., 2019). 4.1. Limitations First, this study is an analysis of cross-sectional data prohibiting us from drawing any causal inference. Accordingly, we describe two opposing potential explanations for our findings and propose that future studies assess PTSD symptoms, APS, and substance use continuously and longitudinally to investigate cau- sal pathways. Especially important are assessments that allow conclusions about times of symptom (PTSD, SUD and APS) onset and the timing of TEs. Second, the groups differ in terms of their gender distribution. While we aimed to correct for this imbal- ance using appropriate statistical methods, this might indicate that the groups differ in additional socio- demographic aspects we have not assessed. Third, APS might lead to and overlap with sub- stance-induced psychotic symptoms and psychoses. Especially in genetically vulnerable adolescents, the use of psychoactive substances such as cannabis, ecstasy, or methamphetamine could contribute to such symptoms and diagnoses (Beckmann et al., 2020). However, none of our SUD outpatients pre- sented acute psychotic symptoms. Even if, these patients would have been transferred to acute inpati- ent treatment. Lacking these patients thus increases the chance to miss an otherwise present association between SUD, PTSD and APS. 4.2. Clinical implications Our results indicate that, in adolescent patients that report APS and co-occurring substance use, an assess- ment of TEs and PTSD is always indicated for a proper differential diagnosis. An integrated treatment of PTSD and SUD is not only warranted given the high comorbidity (Kuitunen-Paul et al., 2021; Wiedmann, Atzendorf, et al., 2022), it may also be possible, albeit this hast to be tested, that that APS might be indirectly alleviated by an integrated treatment of SUD and PTSD. A psychotherapeutic approach integrating therapy for symptoms from different disorders is even more important, given that pharmacological treatment options for either of these disorders and symptoms are heavily limited (Cohen et al., 2010). 5. Conclusion APS in adolescents with SUD seem to be more strongly related to PTSD symptom than substance use. PTSD and a strong prevalence of TEs might be a better explanation for the occurrence of APS in ado- lescents with SUD than the frequency or type of sub- stance use. Clinicians should take care to exclude the possibility of APS being related to a presence of PTSD when suspecting a case of substance-induced psychosis. Ethics approval and consent to participate All procedures of this study were approved by the Institutional Review Board of the University Hospital C. G. Carus Dresden (EK 66022018). Patients as well as legal guardians were informed about the projects thoroughly and comprehensively. Written informed consent was obtained from all legal guardians. Author Contribution LAB analysed the data and wrote the manuscript. MFW participated in writing the manuscript, data analysis, and contributed to the discussion. VR and SKP participated in writing the manuscript and con- tributed to discussion. YG designed the study, 6 L. A. BASEDOW ET AL. participated in writing the manuscript and contribu- ted to discussion. Acknowledgements We thank the SMWK for providing funding and resources to conduct this study. Disclosure statement No potential conflict of interest was reported by the author(s). Funding The Sächsische Aufbaubank -Förderbank-, (grant 100362999 to YG), funded this study. The funding body had no role in designing the study, data collection, analysis and interpretation of the data, or writing the manuscript. Open access funding provided by the Open Access Publish- ing Fund of Philipps-Universität Marburg with support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation). ORCID Lukas Andreas Basedow http://orcid.org/0000-0003- 4866-8686 Melina Felicitas Wiedmann http://orcid.org/0000-0001- 7250-4329 Sören Kuitunen-Paul http://orcid.org/0000-0001-8224- 6490 Veit Roessner http://orcid.org/0000-0002-1873-7081 Yulia Golub http://orcid.org/0000-0002-9191-5884 Data availability statement The datasets used and analysed during the current study are available from the corresponding author (LAB) on reason- able request. References American Psychiatric Association & American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). American Psychiatric Association. Arango, C. (2011). Attenuated psychotic symptoms syn- drome: How it may affect child and adolescent psychiatry. European Child & Adolescent Psychiatry, 20(2), 67–70. https://doi.org/10.1007/s00787-010-0144-2 Arbeitsgruppe Deutsche Child Behavior Checklist. (1998). Fragebogen für Jugendliche; deutsche Bearbeitung der Youth Self- Report Form der Child Behavior Checklist (YSR). (2nd ed.). Arbe- itsgruppe Kinder-, Jugend- und Familiendiagnostik (KJFD). Baeza, I., Graell, M., Moreno, D., Castro-Fornieles, J., Parellada, M., González-Pinto, A., Payá, B., Soutullo, C., de la Serna, E., & Arango, C. (2009). Cannabis use in chil- dren and adolescents with first episode psychosis: Influence on psychopathology and short-term outcome (CAFEPS study). Schizophrenia Research, 113(2), 129– 137. https://doi.org/10.1016/j.schres.2009.04.005 Basedow, L. A., Kuitunen-Paul, S., Eichler, A., Roessner, V., & Golub, Y. (2021). Diagnostic accuracy of the drug use disorder identification test and its short form, the DUDIT-C, in German adolescent psychiatric patients. Frontiers in Psychology, 12, https://doi.org/10.3389/ fpsyg.2021.678819 Basedow, L. A., Kuitunen-Paul, S., Roessner, V., & Golub, Y. (2020). Traumatic events and substance use disorders in adolescents. Frontiers in Psychiatry, 11, https://doi.org/ 10.3389/fpsyt.2020.00559 Basedow, L. A., Kuitunen-Paul, S., Wiedmann, M. F., Roessner, V., & Golub, Y. (2021). Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders. European Journal of Psychotraumatology, 12(1), 1968140. https://doi.org/10. 1080/20008198.2021.1968140 Basedow, L. A., Wiedmann, M. F., Roessner, V., Golub, Y., & Kuitunen-Paul, S. (2022). Coping motives mediate the relationship between PTSD and MDMA use in adoles- cents with substance use disorders. Addiction Science & Clinical Practice, 17(1), 46. https://doi.org/10.1186/ s13722-022-00329-y Beckmann, D., Lowman, K. L., Nargiso, J., McKowen, J., Watt, L., & Yule, A. M. (2020). Substance-induced psy- chosis in youth. Child and Adolescent Psychiatric Clinics of North America, 29(1), 131–143. https://doi.org/10. 1016/j.chc.2019.08.006 Bland, J. M., & Altman, D. G. (1995). Statistics notes: Multiple significance tests: The Bonferroni method. BMJ : British Medical Journal, 310(6973), 170. https:// doi.org/10.1136/bmj.310.6973.170 Brunette, M. F., Mueser, K. T., Babbin, S., Meyer-Kalos, P., Rosenheck, R., Correll, C. U., Cather, C., Robinson, D. G., Schooler, N. R., Penn, D. L., Addington, J., Estroff, S. E., Gottlieb, J., Glynn, S. M., Marcy, P., Robinson, J., & Kane, J. M. (2018). Demographic and clinical correlates of sub- stance use disorders in first episode psychosis. Schizophrenia Research, 194, 4–12. https://doi.org/10. 1016/j.schres.2017.06.039 Carney, R., Yung, A. R., Amminger, G. P., Bradshaw, T., Glozier, N., Hermens, D. F., Hickie, I. B., Killackey, E., McGorry, P., Pantelis, C., Wood, S. J., & Purcell, R. (2017). Substance use in youth at risk for psychosis. Schizophrenia Research, 181, 23–29. https://doi.org/10. 1016/j.schres.2016.08.026 Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed., reprint). Psychology Press. Cohen, J. A., Bukstein, O., Walter, H., Benson, S. R., Chrisman, A., Farchione, T. R., Hamilton, J., Keable, H., Kinlan, J., Schoettle, U., Siegel, M., Stock, S., Medicus, J., & AACAP Work Group On Quality Issues. (2010). Practice parameter for the assessment and treat- ment of children and adolescents with posttraumatic stress disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 49(4), 414–430. https:// doi.org/10.1016/j.jaac.2009.12.020 Cristea, I. A., Kok, R. N., & Cuijpers, P. (2016). The effective- ness of cognitive bias modification interventions for sub- stance addictions: A meta-analysis. PLOS ONE, 11(9), e0162226. https://doi.org/10.1371/journal.pone.0162226 de Jong, Y., Mulder, C. L., Boon, A., Coenders, E., & van der Gaag, M. (2020). Cross validation of the prodromal ques- tionnaire 16-item version in an adolescent help-seeking population. Schizophrenia Bulletin Open, 1(1), Article sgaa033. https://doi.org/10.1093/schizbullopen/sgaa033 Duman, B., Sedes, N., & Baskak, B. (2017). Additive effects of former methylenedioxymethamphetamine and EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 7 http://orcid.org/0000-0003-4866-8686 http://orcid.org/0000-0003-4866-8686 http://orcid.org/0000-0001-7250-4329 http://orcid.org/0000-0001-7250-4329 http://orcid.org/0000-0001-8224-6490 http://orcid.org/0000-0001-8224-6490 http://orcid.org/0000-0002-1873-7081 http://orcid.org/0000-0002-9191-5884 https://doi.org/10.1007/s00787-010-0144-2 https://doi.org/10.1016/j.schres.2009.04.005 https://doi.org/10.3389/fpsyg.2021.678819 https://doi.org/10.3389/fpsyg.2021.678819 https://doi.org/10.3389/fpsyt.2020.00559 https://doi.org/10.3389/fpsyt.2020.00559 https://doi.org/10.1080/20008198.2021.1968140 https://doi.org/10.1080/20008198.2021.1968140 https://doi.org/10.1186/s13722-022-00329-y https://doi.org/10.1186/s13722-022-00329-y https://doi.org/10.1016/j.chc.2019.08.006 https://doi.org/10.1016/j.chc.2019.08.006 https://doi.org/10.1136/bmj.310.6973.170 https://doi.org/10.1136/bmj.310.6973.170 https://doi.org/10.1016/j.schres.2017.06.039 https://doi.org/10.1016/j.schres.2017.06.039 https://doi.org/10.1016/j.schres.2016.08.026 https://doi.org/10.1016/j.schres.2016.08.026 https://doi.org/10.1016/j.jaac.2009.12.020 https://doi.org/10.1016/j.jaac.2009.12.020 https://doi.org/10.1371/journal.pone.0162226 https://doi.org/10.1093/schizbullopen/sgaa033 cannabis Use on subclinical psychotic symptoms. Noro Psikiyatri Arsivi, 54(1), 38–42. https://doi.org/10.5152/ npa.2017.16964 Elhai, J. D., Layne, C. M., Steinberg, A. M., Brymer, M. J., Briggs, E. C., Ostrowski, S. A., & Pynoos, R. S. (2013). Psychometric properties of the UCLA PTSD reaction index. part II: Investigating factor structure findings in a national clinic-referred youth sample. Journal of Traumatic Stress, 26(1), 10–18. https://doi.org/10.1002/ jts.21755 Falukozi, E., & Addington, J. (2012). Impact of trauma on attenuated psychotic symptoms. Psychosis, 4(3), 203– 212. https://doi.org/10.1080/17522439.2011.626867 Frydecka, D., Misiak, B., Kotowicz, K., Pionke, R., Krężołek, M., Cechnicki, A., & Gawęda, Ł. (2020). The interplay between childhood trauma, cognitive biases, and canna- bis use on the risk of psychosis in nonclinical young adults in Poland. European Psychiatry, 63(1), e35. https://doi.org/10.1192/j.eurpsy.2020.31 Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., Valmaggia, L., Cannon, T., Velthorst, E., De Haan, L., Cornblatt, B., Bonoldi, I., Birchwood, M., McGlashan, T., Carpenter, W.,… Yung, A. (2013). The psychosis high-risk state. JAMA Psychiatry, 70(1), 107–120. https://doi.org/10. 1001/jamapsychiatry.2013.269 Fusar-Poli, P., Cappucciati, M., Borgwardt, S., Woods, S. W., Addington, J., Nelson, B., Nieman, D. H., Stahl, D. R., Rutigliano, G., Riecher-Rössler, A., Simon, A. E., Mizuno, M., Lee, T. Y., Kwon, J. S., Lam, M. M. L., Perez, J., Keri, S., Amminger, P., Metzler, S.,… McGuire, P. K. (2016). Heterogeneity of psychosis risk within individuals at clinical high risk: A meta-analytical stratification. JAMA Psychiatry, 73(2), 113–120. https:// doi.org/10.1001/jamapsychiatry.2015.2324 Fusar-Poli, P., Raballo, A., & Parnas, J. (2017). What Is an attenuated psychotic symptom? On the importance of the context. Schizophrenia Bulletin, 43(4), 687–692. https://doi.org/10.1093/schbul/sbw182 Fusar-Poli, P., Tantardini, M., De Simone, S., Ramella- Cravaro, V., Oliver, D., Kingdon, J., Kotlicka-Antczak, M., Valmaggia, L., Lee, J., Millan, M. J., Galderisi, S., Balottin, U., Ricca, V., & McGuire, P. (2017). Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk. European Psychiatry, 40, 65–75. https:// doi.org/10.1016/j.eurpsy.2016.09.003 Gąsior, K. (2018). The links between posttraumatic stress, attachment patterns and quality of life in incarcerated and addicted women. The role of resilience. Psychiatria Polska, 52(6), 1113–1125. https://doi.org/10.12740/PP/ OnlineFirst/76823 Gaudiano, B. A., & Zimmerman, M. (2012). Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpati- ent clinic. The Journal of Clinical Psychiatry, 73(2), 15357. https://doi.org/10.4088/JCP.12m07788 Gawęda, Ł, Göritz, A. S., & Moritz, S. (2019). Mediating role of aberrant salience and self-disturbances for the relation- ship between childhood trauma and psychotic-like experi- ences in the general population. Schizophrenia Research, 206, 149–156. https://doi.org/10.1016/j.schres.2018.11.034 Golub, Y., Basedow, L. A., Meiron Zwipp, J., Kuitunen-Paul, S., & Roessner, V. (2021). DELTA - Dresdner Multimodale Therapie für Jugendliche mit chronischem Suchtmittelkonsum (1st ed.). Hogrefe AG. Hanegraaf, L., van Baal, S., Hohwy, J., & Verdejo-Garcia, A. (2021). A systematic review and meta-analysis of ‘systems for social processes’ in borderline personality and sub- stance use disorders. Neuroscience & Biobehavioral Reviews, 127, 572–592. https://doi.org/10.1016/j. neubiorev.2021.04.013 Hodgekins, J., Lower, R., Wilson, J., Cole, H., Ugochukwu, U., Maxwell, S., & Fowler, D. (2018). Clinician-rated and self-reported psychotic-like experiences in individ- uals accessing a specialist youth mental health service. British Journal of Clinical Psychology, 57(3), 367–381. https://doi.org/10.1111/bjc.12178 Holtzman, C. W., Trotman, H. D., Goulding, S. M., Ryan, A. T., Macdonald, A. N., Shapiro, D. I., Brasfield, J. L., & Walker, E. F. (2013). Stress and neurodevelopmental pro- cesses in the emergence of psychosis. Neuroscience, 249, 172–191. https://doi.org/10.1016/j.neuroscience.2012.12. 017 IBM, Corp. (2020). IBM SPSS Statistics for Windows (27.0). [Computer software]. IBM Corp. Ising, H. K., Veling, W., Loewy, R. L., Rietveld, M. W., Rietdijk, J., Dragt, S., Klaassen, R. M. C., Nieman, D. H., Wunderink, L., Linszen, D. H., & van der Gaag, M. (2012). The validity of the 16-item version of the prodro- mal questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking popu- lation. Schizophrenia Bulletin, 38(6), 1288–1296. https:// doi.org/10.1093/schbul/sbs068 Kelleher, I., Harley, M., Lynch, F., Arseneault, L., Fitzpatrick, C., & Cannon, M. (2008). Associations between childhood trauma, bullying and psychotic symp- toms among a school-based adolescent sample. British Journal of Psychiatry, 193(5), 378–382. https://doi.org/ 10.1192/bjp.bp.108.049536 Kuitunen-Paul, S., Roessner, V., Basedow, L. A., & Golub, Y. (2021). Beyond the tip of the iceberg: A narrative review to identify research gaps on comorbid psychiatric dis- orders in adolescents with methamphetamine use dis- order or chronic methamphetamine use. Substance Abuse, 42(1), 13–32. https://doi.org/10.1080/08897077. 2020.1806183 Loewy, R. L., Bearden, C. E., Johnson, J. K., Raine, A., & Cannon, T. D. (2005). The prodromal questionnaire (PQ): Preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophrenia Research, 79(1), 117–125. https://doi.org/ 10.1016/j.schres.2005.03.007 Majić, T., Brandt, L., & Montag, C. (2022). Anxiety-related symptoms following the sporadic use of ecstasy – a case study. Journal of Psychoactive Drugs, 54(0), 378–385. https://doi.org/10.1080/02791072.2021.2006372 Matheson, S. L., Laurie, M., & Laurens, K. R. (2022). Substance use and psychotic-like experiences in young people: A systematic review and meta-analysis. Psychological Medicine, 1–15. https://doi.org/10.1017/ S0033291722003440 McCrory, E., Foulkes, L., & Viding, E. (2022). Social thin- ning and stress generation after childhood maltreatment: A neurocognitive social transactional model of psychia- tric vulnerability. The Lancet Psychiatry, Article S2215- 0366(22)00202-4. https://doi.org/10.1016/S2215-0366 (22)00202-4 McCusker, C. G. (2001). Cognitive biases and addiction: An evolution in theory and method. Addiction, 96(1), 47–56. https://doi.org/10.1046/j.1360-0443.2001.961474.x McGlashan, T., Walsh, B., Woods, S., McGlashan, T., Walsh, B., & Woods, S. (2010). The psychosis-risk 8 L. A. BASEDOW ET AL. https://doi.org/10.5152/npa.2017.16964 https://doi.org/10.5152/npa.2017.16964 https://doi.org/10.1002/jts.21755 https://doi.org/10.1002/jts.21755 https://doi.org/10.1080/17522439.2011.626867 https://doi.org/10.1192/j.eurpsy.2020.31 https://doi.org/10.1001/jamapsychiatry.2013.269 https://doi.org/10.1001/jamapsychiatry.2013.269 https://doi.org/10.1001/jamapsychiatry.2015.2324 https://doi.org/10.1001/jamapsychiatry.2015.2324 https://doi.org/10.1093/schbul/sbw182 https://doi.org/10.1016/j.eurpsy.2016.09.003 https://doi.org/10.1016/j.eurpsy.2016.09.003 https://doi.org/10.12740/PP/OnlineFirst/76823 https://doi.org/10.12740/PP/OnlineFirst/76823 https://doi.org/10.4088/JCP.12m07788 https://doi.org/10.1016/j.schres.2018.11.034 https://doi.org/10.1016/j.neubiorev.2021.04.013 https://doi.org/10.1016/j.neubiorev.2021.04.013 https://doi.org/10.1111/bjc.12178 https://doi.org/10.1016/j.neuroscience.2012.12.017 https://doi.org/10.1016/j.neuroscience.2012.12.017 https://doi.org/10.1093/schbul/sbs068 https://doi.org/10.1093/schbul/sbs068 https://doi.org/10.1192/bjp.bp.108.049536 https://doi.org/10.1192/bjp.bp.108.049536 https://doi.org/10.1080/08897077.2020.1806183 https://doi.org/10.1080/08897077.2020.1806183 https://doi.org/10.1016/j.schres.2005.03.007 https://doi.org/10.1016/j.schres.2005.03.007 https://doi.org/10.1080/02791072.2021.2006372 https://doi.org/10.1017/S0033291722003440 https://doi.org/10.1017/S0033291722003440 https://doi.org/10.1016/S2215-0366(22)00202-4 https://doi.org/10.1016/S2215-0366(22)00202-4 https://doi.org/10.1046/j.1360-0443.2001.961474.x syndrome: Handbook for diagnosis and follow-up. Oxford University Press. Mongan, D., Shannon, C., Hanna, D., Boyd, A., & Mulholland, C. (2019). The association between specific types of childhood adversity and attenuated psychotic symptoms in a community sample. Early Intervention in Psychiatry, 13(2), 281–289. https://doi.org/10.1111/ eip.12478 Moriyama, T. S., van Os, J., Gadelha, A., Pan, P. M., Salum, G. A., Manfro, G. G., Mari, J. d. J., Miguel, E. C., Rohde, L. A., Polanczyk, G. V., McGuire, P., Bressan, R. A., & Drukker, M. (2019). Differences between self-reported psychotic experiences, clinically relevant psychotic experiences, and attenuated psychotic symptoms in the general population. Frontiers in Psychiatry, 10. https:// doi.org/10.3389/fpsyt.2019.00782. Oswald, S. H., Fegert, J. M., & Goldbeck, L. (2010). Traumafolgestörungen bei Pflegekindern nach Misshandlung und Vernachlässigung. Verhaltenstherapie, 20(1), 37–44. https://doi.org/10.1159/000274622 Pionke-Ubych, R., Frydecka, D., Cechnicki, A., Nelson, B., & Gawęda, Ł. (2021). The indirect effect of trauma via cognitive biases and self-disturbances on psychotic-like experiences. Frontiers in Psychiatry, 12, Article 611069. https://doi.org/10.3389/fpsyt.2021.611069 Rosen, J. L., Miller, T. J., D’Andrea, J. T., McGlashan, T. H., & Woods, S. W. (2006). Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophrenia Research, 85(1), 124–131. https://doi.org/ 10.1016/j.schres.2006.03.034 Ruf, M., Schauer, M., & Elbert, T. (2011). UPID: UCLA PTSD Index for DSM IV (Child version, revision 1, deutsche Fassung). https://kops.uni-konstanz.de/handle/ 123456789/18103 Salazar de Pablo, G., Catalan, A., & Fusar-Poli, P. (2020). Clinical validity of DSM-5 attenuated psychosis syn- drome: Advances in diagnosis, prognosis, and treatment. JAMA Psychiatry, 77(3), 311–320. https://doi.org/10. 1001/jamapsychiatry.2019.3561 Schimmelmann, B. G., Conus, P., Cotton, S., Kupferschmid, S., McGorry, P. D., & Lambert, M. (2012). Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. European Psychiatry, 27(6), 463–469. https://doi.org/10.1016/j.eurpsy.2011.03.001 Scott, J. G., Nurcombe, B., Sheridan, J., & McFarland, M. (2007). Hallucinations in adolescents with post-traumatic stress disorder and psychotic disorder. Australasian Psychiatry, 15(1), 44–48. https://doi.org/10.1080/ 10398560601083084 Sengutta, M., Gawęda, Ł, Moritz, S., & Karow, A. (2019). The mediating role of borderline personality features in the relationship between childhood trauma and psycho- tic-like experiences in a sample of help-seeking non-psy- chotic adolescents and young adults. European Psychiatry, 56(1), 84–90. https://doi.org/10.1016/j. eurpsy.2018.11.009 Simon, A. E., Umbricht, D., Lang, U. E., & Borgwardt, S. (2014). Declining transition rates to psychosis: The role of diagnostic spectra and symptom overlaps in individ- uals with attenuated psychosis syndrome. Schizophrenia Research, 159(2), 292–298. https://doi.org/10.1016/j. schres.2014.09.016 Smith, M. J., Thirthalli, J., Abdallah, A. B., Murray, R. M., & Cottler, L. B. (2009). Prevalence of psychotic symptoms in substance users: A comparison across substances. Comprehensive Psychiatry, 50(3), 245–250. https://doi. org/10.1016/j.comppsych.2008.07.009 Steinberg, A. M., Brymer, M. J., Decker, K. B., & Pynoos, R. S. (2004). The University of California at Los Angeles post-traumatic stress disorder reaction index. Current Psychiatry Reports, 6(2), 96–100. https://doi.org/10. 1007/s11920-004-0048-2 Steinberg, A. M., Brymer, M. J., Kim, S., Briggs, E. C., Ippen, C. G., Ostrowski, S. A., Gully, K. J., & Pynoos, R. S. (2013). Psychometric properties of the UCLA PTSD reac- tion index: Part I. Journal of Traumatic Stress, 26(1), 1–9. https://doi.org/10.1002/jts.21780 Vaiva, G., Boss, V., Bailly, D., Thomas, P., Lestavel, P., & Goudemand, M. (2001). An “accidental” acute psychosis with ecstasy use. Journal of Psychoactive Drugs, 33(1), 95– 98. https://doi.org/10.1080/02791072.2001.10400473 Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., Read, J., van Os, J., & Bentall, R. P. (2012). Childhood adversities increase the risk of psycho- sis: A meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophrenia Bulletin, 38 (4), 661–671. https://doi.org/10.1093/schbul/sbs050 Virani, S., Daya, G. N., Brainch, N., Kotapati, V. P., Zaveri, D., & Ahmed, S. (2018). Persistent psychosis due to single dose of ecstasy. Cureus, 10(7), https://doi.org/10.7759/ cureus.3058 Voluse, A. C., Gioia, C. J., Sobell, L. C., Dum, M., Sobell, M. B., & Simco, E. R. (2012). Psychometric properties of the drug use disorders identification Test (DUDIT) with sub- stance abusers in outpatient and residential treatment. Addictive Behaviors, 37(1), 36–41. https://doi.org/10. 1016/j.addbeh.2011.07.030 Werbeloff, N., Drukker, M., Dohrenwend, B. P., Levav, I., Yoffe, R., van Os, J., Davidson, M., & Weiser, M. (2012). Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Archives of General Psychiatry, 69(5), 467–475. https:// doi.org/10.1001/archgenpsychiatry.2011.1580 Wiedmann,M. F., Atzendorf, J., Basedow, L.A., Roessner, V., Golub, Y., & Kuitunen-Paul, S. (2022). Substanzkonsum, Störungen durch Substanzkonsum und begleitende psy- chische Störungen bei Jugendlichen. Zeitschrift Für Kinder- Und Jugendpsychiatrie Und Psychotherapie. https://doi.org/10.1024/1422-4917/a000846 Wiedmann, M. F., Kuitunen-Paul, S., Basedow, L. A., Roessner, V., & Golub, Y. (2022). Attenuated psychotic symptoms in adolescents with chronic cannabis and MDMA use. Frontiers in Psychiatry, 12, https://doi.org/ 10.3389/fpsyt.2021.696133 Wiers, R. W., Gladwin, T. E., Hofmann, W., Salemink, E., & Ridderinkhof, K. R. (2013). Cognitive bias modification and cognitive control training in addiction and related psychopathology: Mechanisms, clinical perspectives, and ways forward. Clinical Psychological Science, 1(2), 192–212. https://doi.org/10.1177/2167702612466547 EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 9 https://doi.org/10.1111/eip.12478 https://doi.org/10.1111/eip.12478 https://doi.org/10.3389/fpsyt.2019.00782 https://doi.org/10.3389/fpsyt.2019.00782 https://doi.org/10.1159/000274622 https://doi.org/10.3389/fpsyt.2021.611069 https://doi.org/10.1016/j.schres.2006.03.034 https://doi.org/10.1016/j.schres.2006.03.034 https://kops.uni-konstanz.de/handle/123456789/18103 https://kops.uni-konstanz.de/handle/123456789/18103 https://doi.org/10.1001/jamapsychiatry.2019.3561 https://doi.org/10.1001/jamapsychiatry.2019.3561 https://doi.org/10.1016/j.eurpsy.2011.03.001 https://doi.org/10.1080/10398560601083084 https://doi.org/10.1080/10398560601083084 https://doi.org/10.1016/j.eurpsy.2018.11.009 https://doi.org/10.1016/j.eurpsy.2018.11.009 https://doi.org/10.1016/j.schres.2014.09.016 https://doi.org/10.1016/j.schres.2014.09.016 https://doi.org/10.1016/j.comppsych.2008.07.009 https://doi.org/10.1016/j.comppsych.2008.07.009 https://doi.org/10.1007/s11920-004-0048-2 https://doi.org/10.1007/s11920-004-0048-2 https://doi.org/10.1002/jts.21780 https://doi.org/10.1080/02791072.2001.10400473 https://doi.org/10.1093/schbul/sbs050 https://doi.org/10.7759/cureus.3058 https://doi.org/10.7759/cureus.3058 https://doi.org/10.1016/j.addbeh.2011.07.030 https://doi.org/10.1016/j.addbeh.2011.07.030 https://doi.org/10.1001/archgenpsychiatry.2011.1580 https://doi.org/10.1001/archgenpsychiatry.2011.1580 https://doi.org/10.1024/1422-4917/a000846 https://doi.org/10.3389/fpsyt.2021.696133 https://doi.org/10.3389/fpsyt.2021.696133 https://doi.org/10.1177/2167702612466547 Abstract 1. Background 2. Methods 2.1. Participants 2.2. Procedure 2.3. Measures 2.4. Statistical analysis 3. Results 3.1. Participants 3.2. APS in adolescents with SUD 3.3. Association of substance use with APS 4. Discussion 4.1. Limitations 4.2. Clinical implications 5. Conclusion Ethics approval and consent to participate Author Contribution Acknowledgements Disclosure statement ORCID Data availability statement References << /ASCII85EncodePages false /AllowTransparency false /AutoPositionEPSFiles false /AutoRotatePages /PageByPage /Binding /Left /CalGrayProfile () /CalRGBProfile (Adobe RGB \0501998\051) /CalCMYKProfile (U.S. Web Coated \050SWOP\051 v2) /sRGBProfile (sRGB IEC61966-2.1) /CannotEmbedFontPolicy /Error /CompatibilityLevel 1.3 /CompressObjects /Off /CompressPages true /ConvertImagesToIndexed true /PassThroughJPEGImages false /CreateJobTicket false /DefaultRenderingIntent /Default /DetectBlends true /DetectCurves 0.1000 /ColorConversionStrategy /sRGB /DoThumbnails true /EmbedAllFonts true /EmbedOpenType false /ParseICCProfilesInComments true /EmbedJobOptions true /DSCReportingLevel 0 /EmitDSCWarnings false /EndPage -1 /ImageMemory 524288 /LockDistillerParams true /MaxSubsetPct 100 /Optimize true /OPM 1 /ParseDSCComments false /ParseDSCCommentsForDocInfo true /PreserveCopyPage true /PreserveDICMYKValues true /PreserveEPSInfo false /PreserveFlatness true /PreserveHalftoneInfo false /PreserveOPIComments false /PreserveOverprintSettings false /StartPage 1 /SubsetFonts true /TransferFunctionInfo /Remove /UCRandBGInfo /Remove /UsePrologue false /ColorSettingsFile () /AlwaysEmbed [ true ] /NeverEmbed [ true ] /AntiAliasColorImages false /CropColorImages true /ColorImageMinResolution 150 /ColorImageMinResolutionPolicy /OK /DownsampleColorImages true /ColorImageDownsampleType /Bicubic /ColorImageResolution 300 /ColorImageDepth -1 /ColorImageMinDownsampleDepth 1 /ColorImageDownsampleThreshold 1.50000 /EncodeColorImages true /ColorImageFilter /DCTEncode /AutoFilterColorImages false /ColorImageAutoFilterStrategy /JPEG /ColorACSImageDict << /QFactor 0.90 /HSamples [2 1 1 2] /VSamples [2 1 1 2] >> /ColorImageDict << /QFactor 0.40 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /JPEG2000ColorACSImageDict << /TileWidth 256 /TileHeight 256 /Quality 15 >> /JPEG2000ColorImageDict << /TileWidth 256 /TileHeight 256 /Quality 15 >> /AntiAliasGrayImages false /CropGrayImages true /GrayImageMinResolution 150 /GrayImageMinResolutionPolicy /OK /DownsampleGrayImages true /GrayImageDownsampleType /Bicubic /GrayImageResolution 300 /GrayImageDepth -1 /GrayImageMinDownsampleDepth 2 /GrayImageDownsampleThreshold 1.50000 /EncodeGrayImages true /GrayImageFilter /DCTEncode /AutoFilterGrayImages false /GrayImageAutoFilterStrategy /JPEG /GrayACSImageDict << /QFactor 0.90 /HSamples [2 1 1 2] /VSamples [2 1 1 2] >> /GrayImageDict << /QFactor 0.40 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /JPEG2000GrayACSImageDict << /TileWidth 256 /TileHeight 256 /Quality 15 >> /JPEG2000GrayImageDict << /TileWidth 256 /TileHeight 256 /Quality 15 >> /AntiAliasMonoImages false /CropMonoImages true /MonoImageMinResolution 1200 /MonoImageMinResolutionPolicy /OK /DownsampleMonoImages true /MonoImageDownsampleType /Average /MonoImageResolution 300 /MonoImageDepth -1 /MonoImageDownsampleThreshold 1.50000 /EncodeMonoImages true /MonoImageFilter /CCITTFaxEncode /MonoImageDict << /K -1 >> /AllowPSXObjects true /CheckCompliance [ /None ] /PDFX1aCheck false /PDFX3Check false /PDFXCompliantPDFOnly false /PDFXNoTrimBoxError true /PDFXTrimBoxToMediaBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXSetBleedBoxToMediaBox true /PDFXBleedBoxToTrimBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXOutputIntentProfile (None) /PDFXOutputConditionIdentifier () /PDFXOutputCondition () /PDFXRegistryName () /PDFXTrapped /False /Description << /ENU () >> >> setdistillerparams << /HWResolution [600 600] /PageSize [595.245 841.846] >> setpagedevice